Nordic healthcare and biotech growth capital investor KDev Investments, jointly owned by Karolinska Development and Rosetta Capital, has sold its stake in Swedish pharmaceutical research business Inhalation Sciences to Råsunda Förvaltning.
Catch up on essential news and features from this past week with our round-up of industry analysis
With the fresh capital, IM Square plans to acquire three to six additional asset managers
Historical investors, including the Region Paris Venture fund and Sibessor2/Investessor, also take part
Early-stage investors High-Tech Gründerfonds and Bayern Kapital are also taking part